Disc Medicine, Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount
Disc Medicine, Inc. (IRON) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $294.00 thousand as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2026-02-26
- 2025-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $294.00K.
- 2024-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $489.00K.
- 2023-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $323.00K.
- 2023-09-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $369.00K.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2025-12-31 | $294.00K 10-K · filed 2026-02-26 |
| 2024-12-31 | $489.00K 10-K · filed 2025-02-27 |
| 2023-12-31 | $323.00K 10-K · filed 2024-03-21 |
| 2023-09-30 | $369.00K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $424.00K 10-Q · filed 2023-08-11 |
| 2022-12-31 | $151.00K 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |